7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2013-09-30 2013-03-31 2012-12-31 2012-09-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2009-06-30 2009-03-31 
                                                         
      cash flows from operating activities:
    		                                                     
      net earnings
    		1,013,000,000 1,249,500,000 963,200,000 956,300,000 829,300,000 1,184,900,000 878,400,000 859,400,000 1,043,100,000 813,200,000 779,000,000 625,500,000 928,500,000 694,400,000 700,500,000 538,200,000 810,700,000 647,500,000 602,100,000  820,900,000 651,600,000 582,400,000 475,400,000 753,800,000 558,200,000 505,400,000 108,700,000 643,100,000 467,500,000 401,500,000 265,800,000 368,700,000 282,000,000 532,500,000 341,400,000 336,600,000 336,200,000 489,600,000 328,600,000 482,700,000 390,800,000 305,300,000 452,400,000 375,000,000 302,700,000 241,800,000 423,800,000 310,100,000 278,500,000 207,900,000 352,600,000 402,700,000 
      adjustments to reconcile net earnings to cash flows from operating activities:
    		                                                     
      depreciation and amortization
    		146,700,000 147,000,000 151,100,000 138,600,000 135,700,000 144,600,000 140,100,000 141,500,000 137,000,000 136,800,000 135,100,000 130,500,000 129,000,000 126,500,000 129,100,000 126,000,000 126,900,000 126,700,000 131,100,000  120,600,000 117,600,000 117,300,000 109,400,000 103,100,000 97,500,000 99,000,000 99,300,000 96,300,000 94,800,000 87,200,000 82,500,000 77,600,000 73,900,000 73,300,000 72,600,000 68,800,000 69,500,000 70,400,000 80,500,000 81,100,000 77,300,000 78,300,000 81,100,000 79,200,000 79,700,000 79,000,000 81,000,000 82,700,000 75,500,000 76,400,000 79,300,000 77,600,000 
      amortization of deferred contract costs
    		298,600,000 286,100,000 284,500,000 281,400,000 272,600,000 268,300,000 264,400,000 262,300,000 249,500,000 245,100,000 243,500,000 240,900,000 239,400,000 237,600,000 237,300,000 234,800,000 235,600,000 232,600,000 232,300,000  231,400,000 228,700,000 227,300,000 218,800,000 220,600,000 217,700,000 216,900,000                           
      deferred income taxes
    		64,800,000 -15,300,000 -10,200,000 42,700,000 -33,000,000 -26,900,000 -4,300,000 26,800,000 -27,500,000 -10,600,000 20,500,000 34,500,000 -44,300,000 20,800,000 25,600,000 -212,800,000 -39,600,000 -22,200,000 23,500,000  13,600,000 -300,000 44,400,000 5,200,000 -28,900,000 6,600,000 26,400,000 -17,500,000 10,700,000 -39,100,000 46,400,000 -12,200,000 31,900,000 -21,700,000 -14,300,000 7,300,000 29,400,000 25,500,000 -32,400,000 18,700,000 800,000 -4,500,000 7,100,000 700,000 -2,500,000 9,700,000 55,800,000 34,600,000 9,600,000 7,600,000 45,300,000 -18,800,000 23,300,000 
      stock-based compensation expense
    		58,700,000 62,800,000 79,100,000 60,600,000 54,800,000 56,300,000 73,600,000 58,800,000 67,600,000 58,400,000 50,600,000 55,500,000 48,300,000 55,600,000 42,300,000 48,900,000 45,500,000 47,100,000 33,800,000  33,400,000 36,200,000 37,100,000 45,100,000 45,200,000 38,600,000 38,400,000 56,000,000 41,700,000 38,700,000 39,000,000 37,700,000 31,100,000 35,200,000 31,700,000 36,000,000 34,700,000 32,200,000 35,900,000 27,200,000 22,400,000 24,300,000 17,600,000 20,400,000 27,100,000 18,600,000 17,800,000 21,800,000 22,800,000 13,900,000 12,600,000 10,500,000 22,900,000 
      bad debt expense
    		10,300,000 17,100,000 11,900,000 11,200,000 16,100,000                                                 
      net pension income
    		-3,800,000 -5,000,000 -4,900,000 -4,900,000 -5,500,000 -5,800,000 -5,800,000 -5,800,000 -10,700,000 -10,700,000 -9,300,000  -15,800,000 -15,800,000 -15,800,000  -13,900,000 -10,900,000 -11,100,000                                   
      net accretion of discounts and amortization of premiums on available-for-sale securities
    		-22,500,000 -18,300,000 -16,000,000 -15,500,000 -13,400,000 -11,800,000 -11,900,000 -5,500,000                                              
      other
    		2,500,000 6,100,000 3,800,000 900,000 3,700,000 -22,300,000 14,200,000 2,700,000 17,800,000 20,200,000 10,600,000 37,300,000 -11,400,000 3,600,000 3,200,000 17,000,000 15,800,000 -3,700,000 6,100,000  38,400,000 -5,400,000 11,900,000 22,700,000 7,200,000 3,900,000 10,100,000 9,900,000 7,200,000 5,200,000 9,600,000 12,300,000 8,200,000 2,800,000 13,100,000 4,000,000 5,800,000 9,600,000 3,800,000 -24,400,000 7,500,000 4,000,000 9,700,000 16,800,000 -3,100,000 4,300,000 2,600,000 -1,100,000 20,800,000 12,800,000 -800,000 39,400,000 900,000 
      changes in operating assets and liabilities:
    		                                                     
      decrease in accounts receivable
    		102,000,000   115,400,000 12,500,000      201,500,000                                  -103,900,000 106,300,000    27,400,000    
      increase in deferred contract costs
    		-271,400,000 -325,500,000 -295,500,000 -269,800,000 -405,300,000 -327,900,000 -276,100,000 -261,900,000                                              
      increase in other assets
    		-342,400,000 116,100,000 -53,900,000 -217,100,000 68,500,000 87,900,000 -8,700,000 -304,900,000 -197,800,000 -283,900,000 -504,000,000 -321,500,000 -268,300,000 -174,400,000 -494,200,000 -235,400,000 -150,700,000 -188,500,000 -454,800,000  -156,900,000 -213,700,000 -391,700,000 -238,300,000 -154,500,000 -123,200,000 -471,200,000  206,100,000 14,800,000 -259,500,000 -116,200,000 -221,600,000 97,800,000 19,400,000 23,100,000 -249,200,000 -2,400,000 98,300,000 -290,000,000 14,500,000 2,300,000 -330,500,000 -15,900,000 -5,400,000 -117,700,000    -106,300,000   -2,100,000 
      (decrease)/increase in accounts payable
    		-38,000,000                                                     
      decrease in accrued expenses and other liabilities
    		-376,200,000  212,900,000 -323,400,000   231,500,000 -308,600,000  116,000,000 -194,700,000   50,500,000 -413,800,000   -135,800,000 -23,100,000    -91,600,000    -77,800,000      -80,100,000   -15,100,000 -71,900,000   -86,600,000   -73,000,000   -78,800,000  134,300,000 -92,300,000 -68,600,000    
      net cash flows from operating activities
    		642,300,000 1,525,800,000 1,150,300,000 824,400,000 1,300,600,000 1,498,100,000 1,032,400,000 326,500,000 1,404,100,000 899,700,000 718,100,000 912,900,000 971,000,000 1,093,700,000 121,900,000 652,800,000 1,252,200,000 706,400,000 481,900,000  1,118,700,000 698,100,000 432,800,000 732,300,000 1,024,500,000 782,300,000 149,200,000 705,200,000 1,134,900,000 430,400,000 244,700,000 457,200,000 329,800,000 659,100,000 708,100,000 399,500,000 93,200,000 441,400,000 857,100,000 81,300,000 618,300,000   663,200,000 431,600,000 316,300,000 485,500,000 573,000,000 425,000,000 222,300,000 395,500,000 427,500,000 453,500,000 
      cash flows from investing activities:
    		                                                     
      purchases of corporate and client funds marketable securities
    		-3,604,600,000 -1,665,700,000 -1,219,000,000 -2,771,700,000 -2,469,600,000 -3,060,200,000 -595,300,000 -710,200,000 -1,764,000,000 -642,600,000 -3,064,500,000 -1,789,200,000 -3,720,700,000 -2,810,700,000 -2,412,600,000 -2,118,000,000 -3,593,500,000 -2,742,000,000 -812,800,000  -1,019,300,000 -1,465,400,000 -1,409,900,000 -1,696,800,000 -1,425,000,000 -545,000,000 -755,800,000 -1,184,100,000 -1,238,500,000 -1,296,900,000 -1,157,300,000 -912,800,000 -1,171,100,000 -1,635,400,000 -1,801,400,000 -1,579,700,000 -859,800,000 -1,681,500,000 -1,515,000,000 -369,100,000 -1,677,200,000 -1,394,900,000 -765,500,000 -1,417,100,000 -1,138,000,000 -1,095,100,000 -1,149,600,000 -1,053,600,000 -1,482,400,000 -1,085,300,000 -1,161,400,000 -480,500,000 -520,400,000 
      proceeds from the sales and maturities of corporate and client funds marketable securities
    		1,896,000,000 1,258,800,000 1,257,300,000 1,266,800,000 2,414,900,000 2,121,400,000 871,200,000 632,000,000 1,355,800,000 907,000,000 1,618,600,000 882,800,000 1,370,000,000 717,800,000 1,279,100,000 1,078,800,000 2,327,100,000 1,635,800,000 1,196,700,000  1,754,700,000 1,341,500,000 1,653,700,000 818,400,000 927,200,000 623,600,000 539,800,000 752,500,000 836,500,000 858,300,000 1,007,700,000 889,000,000 900,100,000 1,154,200,000 1,397,000,000 1,408,900,000 1,255,300,000 1,223,600,000 1,245,000,000 571,600,000 1,024,300,000 1,234,700,000 602,500,000 852,100,000   989,200,000 756,500,000 732,500,000 826,900,000 814,000,000 1,068,700,000 755,300,000 
      capital expenditures
    		-46,700,000 -36,400,000 -39,400,000 -58,800,000 -54,700,000 -59,600,000 -54,800,000 -39,300,000 -50,300,000 -49,700,000 -45,400,000 -47,600,000 -51,000,000 -39,900,000 -35,900,000 -33,300,000 -64,300,000 -37,500,000 -43,500,000  -38,600,000 -43,900,000 -56,800,000 -41,700,000 -40,300,000 -36,800,000 -43,200,000 -46,500,000 -41,300,000 -45,000,000 -73,300,000 -65,700,000 -48,700,000 -40,900,000 -28,200,000 -43,800,000 -55,600,000 -50,900,000 -27,100,000 -46,400,000 -47,000,000   -37,800,000 -33,200,000 -33,400,000 -59,800,000 -41,400,000 -42,100,000 -38,600,000 -26,400,000 -45,500,000 -28,800,000 
      free cash flows
    		595,600,000 1,489,400,000 1,110,900,000 765,600,000 1,245,900,000 1,438,500,000 977,600,000 287,200,000 1,353,800,000 850,000,000 672,700,000 865,300,000 920,000,000 1,053,800,000 86,000,000 619,500,000 1,187,900,000 668,900,000 438,400,000  1,080,100,000 654,200,000 376,000,000 690,600,000 984,200,000 745,500,000 106,000,000 658,700,000 1,093,600,000 385,400,000 171,400,000 391,500,000 281,100,000 618,200,000 679,900,000 355,700,000 37,600,000 390,500,000 830,000,000 34,900,000 571,300,000   625,400,000 398,400,000 282,900,000 425,700,000 531,600,000 382,900,000 183,700,000 369,100,000 382,000,000 424,700,000 
      additions to intangibles
    		-94,100,000 -101,100,000 -94,800,000 -80,900,000 -91,800,000 -97,500,000 -78,700,000 -87,000,000 -106,900,000 -92,100,000 -86,300,000 -96,700,000 -101,600,000 -87,500,000 -93,200,000 -87,100,000 -92,100,000 -71,700,000 -76,400,000  -93,300,000 -79,500,000 -88,200,000 -74,600,000 -190,600,000 -65,500,000 -73,800,000 -68,900,000 -63,400,000 -62,700,000 -69,700,000 -68,300,000 -57,200,000 -57,400,000 -54,400,000 -60,300,000 -45,400,000 -45,000,000 -47,200,000 -32,800,000 -22,400,000 -25,500,000 -33,500,000 -31,100,000 -27,400,000 -24,000,000 -36,900,000 -23,100,000 -16,400,000 -19,400,000 -36,300,000 -32,200,000 -27,900,000 
      acquisitions of businesses, net of cash acquired
    		500,000 -4,500,000   0 0 0 -33,600,000 -18,000,000   0 0           -5,100,000 0 -700,000 -119,700,000 0 -125,000,000   -700,000 -20,000,000     0 0 -9,700,000 -14,600,000 0 -700,000 -23,500,000 -174,400,000 -1,900,000 -1,300,000 -185,900,000 -113,500,000 -475,300,000 -1,100,000 -40,600,000 -19,200,000 
      proceeds from the sale of property, plant, and equipment and other assets
    		                    0 200,000 23,400,000           0 0   0 0  0             
      net cash flows used in investing activities
    		-1,862,600,000      138,300,000 -216,100,000                  -16,500,000 -452,700,000  -631,700,000 -1,033,700,000 -292,600,000    -10,393,700,000    5,903,300,000        7,294,200,000 -8,496,700,000     4,077,800,000 
      cash flows from financing activities:
    		                                                     
      net increase/(decrease) in client funds obligations
    		573,100,000                  3,203,300,000                                   
      net cash distributed from the internal revenue service
    		-11,500,000  -151,200,000 -336,400,000                                                  
      payments of debt
    		-300,000 -300,000 -300,000 -300,000 -200,000 -200,000 -300,000 -200,000 -200,000 -300,000 -200,000 -200,000 -200,000 -300,000 -200,000 -200,000 -500,000 -500,000 -1,000,600,000  -500,000 -600,000 -500,000 -500,000 -500,000 -600,000 -500,000 -500,000 -500,000 -5,400,000 -900,000 -500,000 -500,000 -500,000 200,000 -600,000 -600,000 -500,000 -600,000 -600,000 -8,300,000 -500,000 -8,200,000 -500,000 -500,000 -500,000 -400,000 -600,000 -400,000 -4,300,000 -1,600,000 -400,000 -8,100,000 
      proceeds from the issuance of debt
    		 0 0 988,900,000            990,400,000 0 0 991,100,000                                   
      settlement of cash flow hedges
    		 0 0 -12,500,000            -1,000,000 0 0 -43,600,000                                   
      repurchases of common stock
    		-366,000,000 -311,600,000 -272,300,000 -372,600,000 -435,500,000 -291,500,000 -254,700,000 -250,000,000 -264,000,000 -220,200,000 -333,300,000 -487,500,000 -491,400,000 -462,500,000 -528,000,000 -469,800,000 -427,400,000 -261,500,000 -213,600,000  -391,200,000 -305,400,000 -309,700,000 -177,100,000 -234,000,000 -299,500,000 -227,100,000 -393,100,000 -187,900,000 -158,200,000 -250,100,000 -302,800,000 -328,600,000 -64,700,000 -318,000,000 -464,900,000 -308,100,000 -429,500,000 -665,500,000 -303,000,000 -95,100,000 -112,400,000 -194,500,000 -102,000,000 -48,700,000 -249,200,000 -558,000,000 -72,700,000 -52,300,000 -49,800,000 -487,200,000 0 -129,200,000 
      net (repurchases)/proceeds from stock-based compensation plans and stock purchase plan
    		-57,800,000                                                     
      dividends paid
    		-626,700,000 -628,000,000 -572,500,000 -572,600,000 -575,100,000 -575,900,000 -516,300,000 -515,800,000 -520,600,000 -432,600,000 -432,900,000 -434,300,000 -437,700,000 -393,800,000 -393,200,000 -396,000,000 -397,800,000 -390,700,000 -391,000,000  -392,900,000 -342,700,000 -343,300,000 -343,400,000 -344,600,000 -302,400,000 -302,600,000 -278,600,000 -278,400,000 -253,000,000 -253,700,000 -255,800,000 -241,800,000 -242,400,000 -242,400,000 -229,800,000 -229,000,000 -231,400,000 -234,900,000 -210,600,000 -210,400,000 -192,200,000 -192,100,000 -192,500,000 -176,200,000 -177,700,000 -179,200,000 -177,600,000 -167,600,000 -168,000,000 -175,300,000 -165,500,000 -166,700,000 
      net proceeds related to reverse repurchase agreements
    		214,800,000 -1,500,000 -641,800,000 297,100,000    273,800,000   54,800,000    22,300,000                                       
      net proceeds from issuance of commercial paper
    		438,500,000                                       2,477,000,000              
      net cash flows provided by/(used in) financing activities
    		164,100,000                  2,524,100,000                                   
      effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents
    		-6,700,000 24,000,000 -53,700,000 17,000,000 -6,700,000 -26,300,000 26,900,000 -16,300,000 -700,000 20,300,000 -44,900,000 -84,500,000 6,700,000 300,000 -21,200,000 3,400,000 -14,300,000 46,800,000 37,900,000 6,900,000 -29,200,000 20,900,000 -33,100,000 5,300,000 -2,000,000 -19,500,000 -12,600,000 -47,300,000 4,000,000 34,900,000 14,200,000                       
      net change in cash, cash equivalents, restricted cash, and restricted cash equivalents
    		-1,062,900,000 -8,405,000,000 13,812,700,000 -7,294,500,000 -10,038,800,000 6,245,500,000 6,917,400,000 -1,809,600,000 4,758,100,000 7,706,500,000 -17,207,000,000 -8,947,600,000 11,196,400,000 -2,658,100,000 10,049,100,000 -6,978,600,000 3,993,300,000 5,766,800,000 3,308,100,000 -1,465,400,000 -4,796,100,000 11,042,900,000 -4,524,000,000 -7,415,300,000 8,727,500,000 1,075,700,000 -2,133,800,000 -6,902,800,000 -414,900,000 7,776,600,000 -2,098,400,000                       
      cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period
    		5,054,600,000 0 0 10,086,000,000  0 0 8,771,500,000 0 0 22,783,000,000  0 0 13,143,200,000  0 0 7,053,600,000  0 0 6,796,200,000  0 0 6,542,100,000  0 0 8,181,600,000                       
      cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period
    		3,991,700,000 -8,405,000,000 13,812,700,000 2,791,500,000  6,245,500,000 6,917,400,000 6,961,900,000 4,758,100,000 7,706,500,000 5,576,000,000  11,196,400,000 -2,658,100,000 23,192,300,000  3,993,300,000 5,766,800,000 10,361,700,000  -4,796,100,000 11,042,900,000 2,272,200,000  8,727,500,000 1,075,700,000 4,408,300,000  -414,900,000 7,776,600,000 6,083,200,000                       
      reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the consolidated balance sheets
    		                                                     
      cash and cash equivalents
    		2,478,000,000 464,200,000 111,500,000 2,104,900,000 -378,300,000 1,650,400,000 199,900,000 1,441,400,000 483,400,000 137,300,000 1,207,700,000 -197,900,000 -110,800,000 142,900,000 1,602,100,000 683,700,000 289,300,000 -10,900,000 1,613,100,000  204,600,000 96,500,000 1,403,900,000 123,000,000 -959,400,000 1,295,300,000 1,490,300,000 -123,600,000 520,200,000 -590,200,000 2,363,600,000                       
      restricted cash and restricted cash equivalents included in funds held for clients
    		1,513,700,000 -8,869,200,000 13,701,200,000 686,600,000 -9,660,500,000 4,595,100,000 6,717,500,000 5,520,500,000 4,274,700,000 7,569,200,000 4,368,300,000 -8,749,700,000 11,307,200,000 -2,801,000,000 21,590,200,000 -7,662,300,000 3,704,000,000 5,777,700,000 8,748,600,000  -5,000,700,000 10,946,400,000 868,300,000 -7,538,300,000 9,686,900,000 -219,600,000 2,918,000,000 -6,779,200,000 -935,100,000 8,366,800,000 3,719,600,000                       
      total cash, cash equivalents, restricted cash, and restricted cash equivalents
    		3,991,700,000 -8,405,000,000 13,812,700,000 2,791,500,000 -10,038,800,000 6,245,500,000 6,917,400,000 6,961,900,000 4,758,100,000 7,706,500,000 5,576,000,000 -8,947,600,000 11,196,400,000 -2,658,100,000 23,192,300,000 -6,978,600,000 3,993,300,000 5,766,800,000 10,361,700,000  -4,796,100,000 11,042,900,000 2,272,200,000 -7,415,300,000 8,727,500,000 1,075,700,000 4,408,300,000 -6,902,800,000 -414,900,000 7,776,600,000 6,083,200,000                       
      supplemental disclosures of cash flow information:
    		                                                     
      cash paid for interest
    		130,300,000 90,400,000 108,800,000 140,700,000 93,000,000 68,100,000 95,800,000 97,000,000 44,000,000 47,800,000 56,700,000 17,700,000 24,000,000 9,200,000 23,900,000 800,000 24,200,000 800,000 27,300,000  33,200,000 17,000,000 53,600,000 18,900,000 35,300,000 23,900,000 49,400,000 14,000,000 32,200,000 12,900,000 41,400,000 8,300,000 33,400,000 3,500,000                    
      cash paid for income taxes, net of income tax refunds
    		73,800,000 253,400,000 518,800,000 64,700,000 379,100,000 215,700,000 502,500,000 87,900,000 241,700,000 479,600,000 57,500,000 268,900,000 222,200,000 310,700,000 55,000,000 403,600,000 207,400,000 317,300,000 45,400,000  169,800,000 304,800,000 45,600,000 196,100,000 157,400,000 241,000,000 39,300,000 106,700,000 33,800,000 347,300,000 41,900,000 247,900,000 36,300,000 231,300,000                    
      increase in accounts receivable
    		 -44,000,000          47,100,000 -507,600,000 25,800,000 -51,800,000 25,400,000 -278,700,000 -7,800,000 -78,700,000  -82,800,000 -102,000,000 -96,800,000  143,300,000 -430,800,000 -239,200,000  97,800,000     321,200,000 -434,600,000   34,500,000 -24,400,000            -17,200,000 -3,600,000 67,700,000 
      increase/(decrease) in accounts payable
    		                  5,700,000                                   
      increase/(decrease) in accrued expenses and other liabilities
    		                              4,600,000             100,900,000          
      proceeds from sale of property, plant, and equipment and other assets
    		 0 0 3,300,000  1,900,000 4,400,000 22,000,000     8,000,000 0 26,200,000  6,000,000 1,600,000 200,000                                   
      net increase in client funds obligations
    		 -8,456,000,000   -9,985,500,000      -15,592,000,000 -7,970,800,000 13,612,900,000 -684,800,000 12,100,600,000 -6,663,700,000 4,963,500,000       -6,916,000,000    -6,359,800,000       10,304,500,000   -3,736,900,000 -5,910,200,000       -5,936,900,000 -7,392,700,000 8,239,500,000 1,805,000,000 3,639,100,000 -7,779,300,000 -5,127,700,000 -4,146,600,000 
      net cash (distributed)/received from the internal revenue service
    		                                                     
      net proceeds from stock purchase plan and stock-based compensation plans
    		 60,100,000 26,600,000 12,000,000 22,600,000 42,100,000 19,100,000 -36,600,000 47,900,000 23,800,000 1,000,000 23,000,000 23,100,000 67,100,000 -16,700,000 30,600,000 34,400,000 47,000,000 -7,900,000  37,700,000 27,700,000 -32,100,000 22,400,000 45,000,000 29,900,000 -24,400,000 23,200,000 51,600,000 9,600,000 -15,100,000  -14,400,000  49,400,000 25,300,000 -22,000,000                 
      net cash flows (used in)/provided by financing activities
    		                                                     
      increase in accounts payable
    		  34,400,000 48,000,000        24,900,000 -21,400,000 42,000,000 -61,900,000 27,100,000 -400,000                                     
      net cash flows from investing activities
    		  -1,257,900,000 -1,644,400,000 -217,200,000      -1,577,600,000 -1,050,700,000 -2,495,300,000 -2,232,000,000 -1,236,400,000 -1,148,600,000 -1,416,800,000 -1,213,800,000 264,200,000    122,200,000 -999,800,000         8,763,900,000    319,200,000   2,504,100,000  -2,859,700,000 715,900,000  -4,314,000,000 5,882,100,000    -4,155,700,000    
      net cash flows from financing activities
    		  13,974,000,000 -6,491,500,000 -11,115,500,000      -16,302,600,000 -8,725,300,000 12,714,000,000 -1,520,100,000 11,184,800,000 -6,486,200,000 4,172,200,000      -5,045,900,000 -7,153,100,000           9,816,700,000   -4,333,100,000 -6,752,800,000  6,426,700,000   6,243,500,000 3,975,600,000 -6,315,400,000 -7,996,600,000 8,205,500,000 1,691,500,000 3,438,800,000  -4,554,500,000 -4,474,600,000 
      net decrease in client funds obligations
    		   -10,870,500,000    -1,374,900,000               -8,063,300,000    -1,711,500,000    -1,674,300,000  -8,928,300,000       -5,295,000,000   -1,220,400,000           
      net proceeds of commercial paper borrowings
    		   4,375,400,000                                                  
      increase in accrued expenses and other liabilities
    		    353,700,000       19,300,000    73,800,000        71,500,000 -92,700,000   2,300,000 40,000,000   30,000,000  -142,700,000    -19,500,000   105,600,000          110,300,000 -31,900,000 -163,200,000 
      net cash received from the internal revenue service
    		    -529,300,000                                                 
      cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of year
    		                                                     
      cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year
    		                                                     
      decrease in accounts payable
    		     9,900,000 11,400,000 -30,400,000 -11,100,000 10,200,000 -30,700,000            -15,100,000    -2,300,000 29,200,000 -28,400,000 21,800,000 -24,500,000  -36,300,000   1,500,000 -19,500,000  -6,500,000 -11,600,000 12,400,000 2,300,000 -31,400,000 2,400,000 10,300,000 -26,500,000  15,900,000 -22,100,000 -36,600,000   -5,800,000 
      net payments related to reverse repurchase agreements
    		     -16,500,000   -9,500,000    0    0                                     
      (increase)/decrease in accounts receivable
    		       -107,900,000                       -81,700,000           -137,300,000 -73,400,000           
      net cash flows used in financing activities
    		       -1,903,700,000                   -1,817,700,000    -2,064,700,000         -3,137,500,000   -1,093,300,000           
      net amortization of premiums and accretion of discounts on available-for-sale securities
    		        1,900,000 7,600,000 16,000,000 24,900,000 27,600,000 25,800,000 22,700,000 20,800,000 20,000,000 16,300,000 12,400,000  14,400,000 14,100,000 12,200,000 11,200,000 11,500,000 13,100,000 14,300,000 15,900,000 17,700,000 18,500,000 19,400,000 19,800,000 23,200,000 23,100,000 23,000,000 23,900,000 24,100,000 24,900,000 25,100,000 22,800,000 19,900,000 19,200,000 18,700,000 15,900,000   12,800,000 13,700,000 14,100,000 13,000,000 13,700,000 14,800,000 14,600,000 
      net (decrease)/increase in client funds obligations
    		                                                     
      net pension expense
    		                    -14,200,000 2,300,000 -2,700,000 14,400,000 9,500,000 14,400,000 17,100,000 322,200,000 2,700,000 2,800,000 2,700,000 6,100,000 6,100,000 4,500,000 4,400,000 4,400,000 4,400,000 3,900,000 3,900,000 7,400,000 10,900,000 10,900,000 10,900,000 9,200,000 9,100,000 9,200,000 10,400,000 10,100,000 10,100,000 10,100,000 8,700,000 8,700,000 8,300,000 
      impairment of assets
    		               12,300,000 2,600,000 2,200,000 2,800,000                                   
      gain on sale of assets
    		              -1,300,000 -6,400,000 -1,600,000 -1,600,000 -200,000  0 -200,000 -1,900,000                     0          
      net (payments)/proceeds related to reverse repurchase agreements
    		                  -13,600,000                                   
      cash provided by:
    		                                                     
      operating activities
    		                                                     
      investing activities
    		                                                     
      financing activities
    		                                                     
      impairment of intangible assets
    		                       0 0 0 12,100,000                           
      changes in operating assets and liabilities, net of effects from acquisitions:
    		                                                     
      (decrease) / increase in accounts payable
    		                                                     
      (decrease) / increase in accrued expenses and other liabilities
    		                    115,800,000                                 
      net cash flows from / (used in) investing activities
    		                                                     
      net payments of reverse repurchase agreements
    		                    0                                 
      net cash flows (used in) / provided by financing activities
    		                                -9,513,600,000                     
      net increase / (decrease) in client funds obligations
    		                                                     
      net proceeds from commercial paper borrowings
    		                      3,536,700,000                               
      net cash flows from / (used in) financing activities
    		                            -922,100,000        1,144,100,000                 
      net proceeds from reverse repurchase agreements
    		                      166,300,000    448,400,000    129,400,000         98,700,000  -428,200,000 441,700,000           
      gain on sale of divested businesses, net of tax
    		                               0  0 0 0 -21,800,000                 
      changes in operating assets and liabilities, net of effects from acquisitions and divestitures of businesses:
    		                                                     
      proceeds from the sale of divested businesses
    		                               0  0 0 -300,000 162,500,000                 
      proceeds from the sale of property, plant, and equipment
    		                        0                             
      increase / (decrease) in accounts payable
    		                                                     
      net (decrease) / increase in client funds obligations
    		                                    -275,100,000                 
      decrease in other assets
    		                                                     
      proceeds from debt issuance
    		                                                     
      gain on sale of building
    		                                 0 0                3,800,000   
      decrease/(increase) in accounts receivable
    		                                                     
      proceeds from the sale of notes receivable
    		                                     0 1,200,000               
      operating activities of discontinued operations
    		                                     -800,000 0  0 1,300,000 100,000        0   
      net decrease/(increase) in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                                     
      dividend received from cdk global, inc.
    		                                     0 0               
      cash retained by cdk global, inc.
    		                                     0 0               
      investing activities of discontinued operations
    		                                     -1,300,000 0  0          0   
      net cash flows provided by/(used in) investing activities
    		                                                     
      proceeds from stock purchase plan and exercises of stock options
    		                                     21,400,000 58,900,000 61,200,000 59,800,000 49,300,000 80,200,000 72,100,000 69,300,000 48,900,000 132,700,000 216,900,000 106,800,000 21,800,000 39,800,000 7,600,000 -24,000,000 
      net repayments from issuance of commercial paper
    		                                                     
      financing activities of discontinued operations
    		                                     -100,000 0               
      effect of exchange rate changes on cash and cash equivalents
    		                               25,500,000 5,400,000 -5,500,000 15,400,000 -9,800,000 -11,100,000 6,200,000 -49,800,000 2,000,000 -12,600,000 4,400,000 11,800,000 10,000,000 -10,800,000 -23,500,000 5,400,000 13,400,000 -5,100,000 28,000,000 -15,600,000 35,400,000 1,800,000 
      net change in cash and cash equivalents
    		                               -215,100,000 -414,500,000 249,700,000 146,500,000 -389,800,000 1,545,400,000 -169,300,000 -42,200,000 -550,100,000 256,800,000 273,500,000 -430,700,000 333,800,000 82,400,000 -140,500,000 -211,500,000 295,200,000 129,000,000 -466,600,000 -321,700,000 901,900,000 58,500,000 
      cash and cash equivalents, beginning of period
    		                               0 3,191,100,000 0 0 0 1,639,300,000 0 0     0 0 1,389,400,000  0 0 1,643,300,000    
      cash and cash equivalents, end of period
    		                               -215,100,000 2,776,600,000 249,700,000 146,500,000 -389,800,000 3,184,700,000 -169,300,000 -42,200,000     333,800,000 82,400,000 1,248,900,000  295,200,000 129,000,000 1,176,700,000    
      net decrease / (increase) in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                9,160,800,000                     
      net proceeds from debt issuance
    		                                  12,000,000 -100,000 1,986,400,000                 
      decrease / (increase) in accounts receivable
    		                                121,000,000                     
      excess tax benefit related to exercise of stock options and restricted stock
    		                                 -3,800,000 -10,900,000 -6,800,000 -15,900,000 -20,500,000 500,000               
      net realized loss / (gain) from the sales of marketable securities
    		                                                     
      net (increase) / decrease in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                    -137,800,000                 
      net cash flows (used in) / provided by investing activities
    		                                                     
      net repayments from reverse repurchase agreements
    		                                                     
      net (repayments) / proceeds from issuance of commercial paper
    		                                                     
      less cash and cash equivalents of discontinued operations, end of period
    		                                                     
      cash and cash equivalents of continuing operations, end of period
    		                                 249,700,000 146,500,000 -389,800,000 3,184,700,000 -169,300,000 -42,200,000 1,149,000,000 256,800,000 273,500,000 1,117,400,000           
      net increase in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                  -9,906,700,000    6,247,600,000         -7,947,700,000 -1,064,100,000 -3,380,400,000    
      net repayments of commercial paper borrowings
    		                                      0               
      (increase) / decrease in accounts receivable
    		                                    -32,300,000                 
      net realized gain from the sales of marketable securities
    		                                     -2,600,000 -600,000 -3,500,000 -6,000,000 -9,300,000 -4,500,000 -3,600,000 -8,200,000 -4,000,000    -11,800,000  -2,500,000 6,600,000 
      goodwill impairment
    		                                                     
      gains on sales of buildings
    		                                        0       0 0 -1,800,000    
      gain on sale of discontinued businesses, net of tax
    		                                        0           -5,400,000 0 
      net decrease in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                       2,390,500,000   943,600,000           
      proceeds from the sale of businesses included in discontinued operations
    		                                        0          0   
      net (repayments of) / proceeds from reverse repurchase agreements
    		                                                     
      net (repayments of) / proceeds from issuance of commercial paper
    		                                                     
      proceeds from the sale of business included in discontinued operations
    		                                                     
      net repayments of reverse repurchase agreements
    		                                                     
      (decrease)/increase in accrued expenses and other liabilities
    		                                                     
      impairment losses on available-for-sale securities
    		                                           0       9,100,000   
      impairment losses on assets held for sale
    		                                              3,100,000 0 0 8,600,000    
      changes in operating assets and liabilities, net of effects from acquisitions
    		                                                     
      and divestitures of businesses:
    		                                                     
      cash and cash equivalents of continuing operations, beginning of period
    		                                       1,699,100,000 0 0 1,548,100,000          0 
      decrease (increase) in accounts receivable
    		                                       12,200,000              
      adjustments to reconcile net earnings to cash flows from operating activities
    		                                                     
      changes in operating assets and liabilities, net of effects from acquisitions and divestiture of business:
    		                                                     
      adjustments to reconcile net earnings to cash flows provided by
    		                                                     
      operating activities:
    		                                                     
      net (increase)/decrease in restricted cash and cash equivalents held to satisfy client funds obligations
    		                                                     
      net cash flows (used in)/provided by operating activities
    		                                          -65,100,000           
      proceeds from the sale of property, plant and equipment and other assets
    		                                           0          
      net amortization of premiums and accretion of discounts
    		                                                     
      on available-for-sale securities
    		                                             12,800,000        
      changes in operating assets and liabilities, net of effects
    		                                                     
      from acquisitions and divestitures of businesses:
    		                                                     
      proceeds from the sales and maturities of corporate
    		                                                     
      and client funds marketable securities
    		                                             844,300,000        
      net decrease (increase) in restricted cash and cash equivalents
    		                                                     
      held to satisfy client fund obligations
    		                                             6,192,200,000        
      proceeds from the sale of property, plant and equipment
    		                                              0 0 100,000 13,000,000 0 5,800,000 0 
      cash flows from operating activities
    		                                                     
      excess tax benefit related to exercises of stock options
    		                                                     
      net realized (gain) income from the sales of marketable securities
    		                                                     
      gain on sales of buildings
    		                                                     
      (increase) in accounts receivable
    		                                                     
      cash flows from investing activities
    		                                                     
      net increase in restricted cash and cash equivalents and other restricted assets held to satisfy client funds obligations
    		                                                   4,515,000,000 3,915,900,000 
      reclassification from cash and cash equivalents to short-term marketable securities
    		                                                   0 0 
      cash flows from financing activities
    		                                                     
      proceeds from issuance of debt
    		                                                   0 0 
      net purchases of reverse repurchase agreements
    		                                                    0 
      net (repayment) proceeds of commercial paper borrowing
    		                                                     
      cash and cash equivalents of continuing operations, beginning of year
    		                                                     
      cash and cash equivalents of discontinued operations, beginning of year
    		                                                     
      cash and cash equivalents, end of year
    		                                                     
      less cash and cash equivalents of discontinued operations, end of year
    		                                                     
      cash and cash equivalents of continuing operations, end of year
    		                                                     
      net realized (gain)/income from the sales of marketable securities
    		                                               -4,300,000      
      (increase)/decrease in other assets
    		                                               -12,500,000      
      net repayment of commercial paper
    		                                                     
      changes in operating assets and liabilities, net of effects from acquistions and divestitures of businesses:
    		                                                     
      decrease (increase) in other assets
    		                                                  -125,100,000   
      net (purchases of) proceeds from reverse repurchase agreements
    		                                                     
      net cash flows from (used in) financing activities
    		                                                     
      net realized income from the sales of marketable securities
    		                                                     
      (gain) loss on sale of discontinued businesses, net of tax
    		                                                     
      net increase in restricted cash and cash equivalents and other restricted assets
    		                                                     
      held to satisfy client funds obligations
    		                                                     
      net repayment of commercial paper borrowing
    		                                                     
      cash and cash equivalents of discontinued operations, beginning of period
    		                                                     
      gain on sale of cost-based investment
    		                                                     
      (increase) in other assets
    		                                                     
      proceeds from the sale of cost-based investment
    		                                                     
      dividend received from broadridge financial solutions, inc., net of 29.9 million in cash retained by broadridge financial solutions, inc.
    		                                                     
      proceeds from the sale of businesses included in discontinued operations, net of cash divested
    		                                                     
      gain on sale of assets held for sale
    		                                                    0 
      impairment of assets of discontinued operations businesses
    		                                                     
      net decrease (increase) in restricted cash and cash equivalents and other restricted assets held to satisfy client funds obligations
    		                                                     
      see notes to consolidated financial statements.
    		                                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.